Vizega
FOR PATIENTS
  • Hormonal treatment
  • A growth hormone
  • Obesity problem
  • Hemophilia
COMPANY
  • History
  • Mission
  • Corporate social responsibility
PRODUCTS
  • Neurology and cardiology
  • Oncology
  • Androgens and other hormones
  • Anesthetics and dilution fluids
  • Pulmonology and men's health treatment
QUALITY
  • Checking the authenticity and quality of drugs
  • Report an adverse event
NEWS
CONTACT
    Vizega
    FOR PATIENTS
    • Hormonal treatment
    • A growth hormone
    • Obesity problem
    • Hemophilia
    COMPANY
    • History
    • Mission
    • Corporate social responsibility
    PRODUCTS
    • Neurology and cardiology
    • Oncology
    • Androgens and other hormones
    • Anesthetics and dilution fluids
    • Pulmonology and men's health treatment
    QUALITY
    • Checking the authenticity and quality of drugs
    • Report an adverse event
    NEWS
    CONTACT
      Vizega
      • FOR PATIENTS
        • Назад
        • FOR PATIENTS
        • Hormonal treatment
        • A growth hormone
        • Obesity problem
        • Hemophilia
      • COMPANY
        • Назад
        • COMPANY
        • History
        • Mission
        • Corporate social responsibility
      • PRODUCTS
        • Назад
        • PRODUCTS
        • Neurology and cardiology
        • Oncology
        • Androgens and other hormones
        • Anesthetics and dilution fluids
        • Pulmonology and men's health treatment
      • QUALITY
        • Назад
        • QUALITY
        • Checking the authenticity and quality of drugs
        • Report an adverse event
      • NEWS
      • CONTACT
      114 Dr. E.Moses Road, Mumbai - 400 018, India

      Industry Scenario of India

      • Home
      • News
      • Industry Scenario of India
      The healthcare industry in India is expected to reach $372 billion by 2022.
      June 2, 2021
      The healthcare industry in India includes hospitals, medical equipment, clinical trials, outsourcing, telemedicine, medical tourism, health insurance and medical equipment. The healthcare sector is growing at a tremendous pace, driven by increased coverage, services and spending by both public and private players.

      • The hospital industry in India, which accounts for 80% of the entire healthcare market, is witnessing huge investment demand from both global and local investors. The hospital industry is expected to reach $132 billion by 2023, up from $61.8 billion in 2017; is growing at an average annual growth rate of 16-17%.
      • India's medical tourism market is expected to grow from the current $3 billion to $7-8 billion by 2020.
      • The diagnostics industry in India is currently valued at $4 billion. The share of the organized sector in this segment is almost 25% (15% in laboratories and 10% in radiology).
      • The primary health care industry is currently valued at $13 billion. The share of the organized sector in this case is practically negligible.
      • 70,000 Ayushman Bharat centers that aim to provide primary health care services to communities closer to their homes operate in India.
      • The share of health insurance in the non-life insurance business is 20%, making it the second largest portfolio. Gross income from direct health insurance premiums grew 17.16% year-over-year to $6.87 billion in FY20.


      The Loan Guarantee Scheme for Covid Affected Sectors (LGSCAS) offers guarantee coverage for financing provided by registered commercial banks for eligible projects in the healthcare sector to establish or modernize/expand healthcare facilities.
      Our experts will answer any question of interest
      Ask question

      © 2026 Vizega Ltd. All rights reserved. Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Vizega its subsidiaries or affiliates.
      114 Dr. E.Moses Road, Mumbai - 400 018, India